Jul 15-16, 2019

New York, United States of America

Novel Drug Delivery Systems Congress 2019

Lexis Conferences Ltd connects participants together from all around the globe to contribute at Novel Drug Delivery Systems Congress 2019 scheduled during July 15-16, 2019 at New York, USA.

Novel Drug Delivery Congress 2019 will illustrate innovative research ideas on Advanced Drug Delivery Systems, Drug Targeting and Design, Nano medicine & Nanotechnology, Pharmaceutical Technology, Medicinal Chemistry and Drug Discovery and Screening, Formulation Technology, Bio pharmaceutics and Biologic Drugs, Medical Devices for Drug Delivery.The conference opens the doors for many eminent personalities such as Researchers and Ph.D Scholars from academia, Clinicians, R&D Researchers, CEOs, CROs, CMOs, Director, President from Pharmaceutical Companies, Manufacturers, Distributors and Suppliers of Drug Delivery Technologies, Business Entrepreneurs, Health professionals & Pharmacist, Quality control specialist. It provides interdisciplinary platform to present and discuss the most recent innovations, trends as well as practical challenges encountered and solutions adopted in the fields Novel Drug Delivery Systems.

The global drug delivery systems market was valued approximately US$ 510.0 Bn in 2016 and is anticipated to expand at a CAGR of over 6.9% from 2017 to 2025 to reach approximately US$ 900 Bn by 2025. The North America Novel Drug Delivery Systems market is expected to witness a CAGR of 8.7% during the forecast period, 2018-2023. Key companies operating in the global drug delivery systems market and profiled in the report include AstraZeneca plc., Bayer AG, Pfizer, Inc., Novartis AG, Amgen Inc., Johnson and Johnson Services, Inc., Baxter International, Inc., Boston Scientific Corporation, and Becton, Dickinson & Company

Some of the factors driving the growth of the market are:

  • Increased prevalence of chronic diseases
  • Technological advances
  • Increase in individual therapy
  • Increased understanding about drug metabolism among the population
  • Requirement of controlled drug release


Prof Dr Heyam Saad Ali
Pharmaceutics Department
Dubai Pharmacy College, UAE


Prof. Dr. Heyam Saad Ali, Ph-D –She is working in pharmaceutics department in Dubai Pharmacy College, UAE. Prof. contributed more than 70 articles to reputed international scientific journals and conferences, in different conventional, controlled and targ

Program Overview

Our Collaborations, Sponsors, Media Partners